Barozet Tablet 10/10 mg
Ezetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
Anguk New Pharm Co., Ltd.
MFDS item code 201901142 · Approved 2019.02.22
This product's status changed to Expired on 2024.02.22. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia
This medication helps to lower total cholesterol, LDL cholesterol, ApoB protein, and triglyceride levels while increasing HDL cholesterol in patients with primary hypercholesterolemia and mixed hyperlipidemia. It is particularly used as an adjunct to diet in patients with heterozygous familial and non-familial hypercholesterolemia. For homozygous familial hypercholesterolemia patients, it can be used in conjunction with or as a sole treatment to control cholesterol levels. This medication is recommended to be used with appropriate dietary management, especially for those who show insufficient response to other non-drug treatments. Prior to administration, secondary causes such as diabetes and hypothyroidism should be confirmed and treated if necessary, and treatment direction should be based on lipid test results. This drug is used to effectively improve blood lipid levels for treating hypercholesterolemia and resultant atherosclerosis.
Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug. The dosage of this drug should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This drug is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dosage range for this drug is 10/10mg to 10/40mg once daily. The generally recommended initial dose is 10/20mg once daily. Patients who require less LDL cholesterol reduction may start with 10/10mg once daily. After starting this drug or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of at least 4 weeks. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this drug should be used only in patients who have been taking this drug at 10/80 mg for 12 months or longer without evidence of muscle toxicity (see Precautions for Use, 1. Warnings). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily, administered in the evening. This drug is used as an adjunct to other lipid-lowering therapy (e.g., LDL apheresis) or when other lipid-lowering therapies are not useful. Administration to patients with hepatic impairment No dosage adjustment is necessary for patients with mild hepatic impairment; however, use of this drug is not recommended in patients with moderate or severe hepatic impairment (see Precautions for Use, 4. General Precautions, Patients with Abnormal Liver Function). Administration to patients with renal impairment and patients with chronic kidney disease No dosage adjustment is necessary for patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). Patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡ should receive 10/20mg of this drug once daily in the evening. When administering higher doses of this drug to these patients, use caution and monitor them closely (see Precautions for Use, 4. General Precautions). Administration to elderly patients No dosage adjustment is necessary in elderly patients. Concomitant administration with other drugs (See Precautions for Use, 5. Interactions.) This drug should be administered at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this drug concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this drug. Patients receiving this drug concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this drug.
This medication can cause serious muscle disorders such as myopathy and rhabdomyolysis, so if muscle pain, muscle weakness, or unexplained muscle pain occurs during treatment, consult a physician immediately. This medication should not be administered to patients with specific liver diseases or poor liver function, and regular liver function tests are necessary if liver dysfunction is suspected. Women who are pregnant or breastfeeding should not use this medication, and women of childbearing potential must consult a physician before use and utilize appropriate contraception. This medication may interact with other drugs, especially medications that inhibit enzymes involved in drug metabolism in the liver, which could increase the risk of muscle damage; therefore, inform healthcare professionals of any other medications being taken. Elderly patients or those with reduced kidney function should also exercise caution when taking this medication, and dosage adjustments or regular testing is recommended. In some patients, blood sugar may rise due to this medication; thus, regular blood sugar testing is necessary for those at risk of diabetes. While taking this medication, consumption of certain foods, such as grapefruit juice, should be limited, and immediate treatment is required in case of overdose, so strictly adhere to the dosage. This medication is used restrictively in children and adolescents, particularly not recommended for children under 10 years old. If any adverse reactions or discomfort persist after administration, inform healthcare professionals immediately, and regular blood tests to monitor liver function and muscle status are important.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container that protects against air and moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius. This helps to preserve the medication's effectiveness and prevent degradation.
White to pale yellow, biconvex, rectangular tablet
30 tablets (10 tablets/PTP ×3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ezetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
Anguk New Pharm Co., Ltd.
CombinationSimvastatin 10mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationSimvastatin 20mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationSimvastatin 40mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
Ezetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
Ezetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
Suhung Co., Ltd.
CombinationEzetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Seohung Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.